A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy

The purpose of this study is to evaluate the efficacy and safety of investigational doses of dulaglutide in participants with type 2 diabetes on metformin monotherapy.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Type 2 Diabetes
What the trial is testing?
Dulaglutide
Could I receive a Placebo?
Yes
Enrollment Goal
318
Trial Dates
Dec 1, 2016 - Aug 14, 2017
How long will I be in the trial?
Your participation could last up to 22 weeks and include 13 visits to the study center.
Trial Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.